🔴 Eupraxia Pharmaceuticals is trading 7.88% down in pre-market with no company-specific catalyst identified

Eupraxia Pharmaceuticals is trading 7.88% down in pre-market at $6.20, with no confirmed company-specific catalyst identified.

• The decline follows the August 21, 2026, close of $6.73.
• Searches found no new announcement, earnings release, regulatory action, analyst move, or other confirmed overnight catalyst.
• Recent RESOLVE trial data and second-quarter results do not directly explain the August 24 movement.